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Abstract:   
 
Purpose: The primary aim of the present study was to elicit a WTP estimate for a health 
improvement targeting the general Greek population. Moreover, it intended to investigate 
socioeconomic, demographic and determinants differences between those willing to pay for a 
health improvement and those not willing to pay for such an improvement (protest 
responders). 
Design/Methodology/Approach: A specially designed questionnaire employing the iterative 
bidding technique and the EuroQoL-5D-3L tool was used. A representative sample of the 
general Greek population (n=1,342) completed the questionnaire via telephone interviews –
computer-assisted telephone interview method for random sample selection. Socioeconomic, 
demographic and determinants differences between participants willing to pay (n=528) and 
protest responders (n=395) were assessed through Chi-square and Mann-Whitney U Test. 
Findings: The average WTP estimate for a health improvement was €26,280. Participants 
willing to pay for a health improvement differed significantly from protest responders with 
respect to age (p=0.000), household size (p=0.018), number of household members having a 
part- or full-time job (p=0.000), education (p=0.000), marital status (p=0.000), household 
income (p=0.000) and utility (p=0.003). Respondents willing to pay for the hypothetical 
treatment differed significantly from protest responders with respect to their views towards 
quality of healthcare services and healthcare personnel (p=0.000 and 0.005, respectively). 
Practical Implications: Preliminary findings revealed that, when the general Greek 
population is considered, the WTP estimate for a health improvement falls within the World 
Health Organization’s criterion currently used in Greek healthcare economic evaluations.   
Originality/Value: To the best of our knowledge, this is the first study aiming at eliciting a 
monetary value for a health improvement targeting the general Greek population and 
identifying socioeconomic differences between willing and not willing to pay individuals.     
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The present study falls within the wider research area of health economics. The 
health sector is one of the most important sectors within a country’s economy, as it 
absorbs a substantial part of the Gross Domestic Product (GDP) (OECD, 2017) and 
is closely related to ensuring and maintaining citizens’ quality of life. It is, therefore, 
particularly important for a country to establish state-level health policies with 
specific goals in order to succeed in improving people’s quality of life. On that 
ground, scientific research in the field of health economics is perhaps one of the 
most powerful lever for the formulation of specific strategies and targeted health 
policies, as it provides the necessary tools for developing and adopting methods that 
lead both to saving valuable resources and guiding quality in health services 
provision.   
 
During the past decades, sustainability of healthcare systems due to increased 
healthcare needs and scarcity of healthcare resources constitutes a major challenge 
in the health sector. Hence, economic evaluation has been widely adopted by 
healthcare policy-makers to facilitate informed decision-making in budged 
allocation and reimbursement of medical interventions (Tilling et al., 2016; Ryen 
and Svensson, 2015; Drummond et al., 2015). In the context of economic 
evaluation, the Contingent Valuation (CV) Method constitutes a tool that can be 
used to assess values related to people’s preferences (Drummond et al., 2015; Gyrd-
Hansen, 2003).  
 
More specifically, this method aims at determining the maximum willingness-to-pay 
(WTP) for a medical treatment/technology/intervention with no market value 
(Bobinac et al., 2010; Gyrd-Hansen, 2003; Bateman et al., 2002). This WTP value is 
then combined with a health improvement/outcome offered by this specific 
treatment. One way to measure this health improvement/outcome is by using 
Quality-Adjusted Life-Years (QALYs). QALYs constitute a common measurement 
unit assessing both duration and quality of life (QoL) and allowing comparison 
among different economic evaluation studies (Drummond et al., 2015). This WTP 
per QALY value defines a threshold that renders a treatment/technology/intervention 
as cost-effective with respect to its reimbursement (Drummond et al., 2015; Bobinac 
et al., 2012).  
 
Last but not least, it is important to mention that WTP per QALY seems to be 
affected by people’s socioeconomic and demographic characteristics (Lim et al., 
2017; Mavrodi et al., 2017; Sund and Svensson, 2017; Gao et al., 2015; Alayli-
Goebbels et al., 2014; Zhao et al., 2011; Bobinac et al., 2010; Shiroiwa et al., 2010; 
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King et al., 2005; Gyrd-Hansen, 2003) and determinants associated with healthcare 
services provision satisfaction (Gyrd-Hansen, 2016; Shiroiwa et al., 2010).  
 
In Greece, due to the necessity to allocate efficiently a shrunk healthcare national 
budget, focusing on assigning a monetary value to a QALY and thus set such cost-
effectiveness threshold for reimbursement purposes is vital. So far, Greek economic 
evaluations adopt the World Health Organisation (WHO) recommendation of one to 
three times the country’s GDP per capita to assess cost-effectiveness of treatments 
(Terpos et al., 2019; Tzanetakos et al., 2018; Marseille et al., 2015). Nevertheless, 
no research has yet examined the appropriateness of this threshold for decision-
making within the Greek healthcare environment.  
 
Furthermore, in Greece, WTP per QALY estimates have only been elicited for 
specific treatments and patient populations (Terpos et al., 2019; Tzanetakos et al., 
2018; Mavrodi et al., 2017; Kontodimopoulos and Niakas, 2006). To the best of our 
knowledge, no previous empirical research has targeted the general Greek 
population for eliciting a WTP per QALY estimate. This estimate could facilitate 
policy-making by aiding financial healthcare resources allocation; a very important 
aspect for the Greek health sector when considering the economic austerity of the 
last decade. 
 
The main aim of the present study was to elicit a WTP estimate for an additional 
QALY targeting the general Greek population via the CV method. Moreover, it 
intended to investigate demographic, socioeconomic, and determinants differences 
between those willing to pay for an additional QALY and those not willing to pay 
(protest responders).  
 
2. Literature Review  
 
Economic evaluation in the health sector is defined by Drummond et al. (2015) as 
“the comparative analysis of alternative courses of action in terms of both their 
costs and consequences”. Therefore, economic evaluations describe cost/benefit 
comparisons of alternative treatments. In most economic evaluations, costs are 
measured in a unanimous way (in monetary terms), whereas benefits measurement 
units differ significantly (Drummond et al., 2015). The latter has led to the 
development of several economic evaluation methods addressing these differences 
in benefits comparisons.  
 
Such methods are the cost-consequence analysis, the cost-minimisation analysis, the 
cost-effectiveness analysis, the cost-utility analysis and the cost-benefit analysis 
(Drummond et al., 2015; Gray et al., 2012). Within healthcare, using non-monetary 
values, like QALYs, for assessing treatment benefits is widely accepted (Tilling et 
al., 2016), rendering cost-utility and cost-effectiveness analyses as the preferable 
economic evaluation methods among researchers (Ryen and Svensson, 2015).  
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2.1 State Preference Techniques (SPTs) 
Within the economic evaluation framework, a treatment’s benefit on an individual’s 
health can be monetised via two techniques: the revealed preference technique 
(RPT) and the stated preference technique (SPT) (Gray et al., 2012; Bateman et al., 
2002). The first deals with individuals’ preferences revealed via their actual 
decisions and choices, whereas the second with the stated value an individual 
assigns to a benefit (McIntosh et al., 2010; Bateman et al., 2002). Healthcare market 
is not perfect due to risk, uncertainty, externalities, information asymmetry and 
oligoly. Therefore, the value assigned to a healthcare benefit is more accurately 
measured via SPTs (McIntosh et al., 2010).  
 
SPT consists of two methods: the choice modelling method (CMM) and the 
contingent valuation method (CVM). CMM focuses on individuals’ preferences 
regarding specific characteristics and properties of a treatment, whereas CVM aims 
at obtaining a monetary estimate for the perceived value of a treatment as a whole 
(Gray et al., 2012). CVM is widely used in the healthcare sector, since it offers 
relatively easy to interpret and use results (Fonta, Ichoku and Kabubo-Mariara, 
2010) and allows evaluation of services with which users have limited or no prior 
experience (McIntosh et al., 2010).   
  
2.2 Contingent Valution Method (CVM) 
In CVM respondents are asked to consider a scenario for a hypothetical treatment, 
not yet available in the market, and state their maximum WTP to ensure the benefit 
of this treatment (Bateman et al., 2002). WTP value can be elicited through a 
number of methods. Based on the literature, the most frequently used elicitation 
methods are: a) open-ended question (Gyrd-Hansen and Kjaer, 2012; Byrne, 
O’Malley and Suarez, 2005), b) iterative bidding technique (Mavrodi et al., 2017; 
Martín-Fernández et al., 2014; Zhao et al., 2010; King et al., 2005), c) payment 
card/scale (Bobinac et al., 2010; Pinto-Prades, Loomes and Brey, 2009), and d) 
dichotomous choice question (Shiroiwa et al., 2013; Gyrd-Hansen and Kjaer, 2012; 
Shiroiwa et al., 2010). The open-ended question constitutes the simplest and easiest 
to apply approach. Respondents are free to state any monetary value they are willing 
to pay.  
 
However, it has high non-response rate, zero responses and outliers are more 
frequent and is less reliable since respondents report a value for a treatment with 
which they are not familiar (Fonta, Ichoku and Kabubo-Mariara, 2010). Iterative 
bidding technique introduces the respondent to a bidding game, where he has to 
accept or reject an already provided value (bid). Payment card is a technique based 
on visual aids, where respondents have to select their preferred maximum value over 
a list of pre-defined values presented on a card (McIntosh et al., 2010). This method 
cannot be used in telephone surveys. With dichotomous choice question (either 
single- or double-bounded) respondents are presented with a set value and they have 
to either accept or reject it (yes/no answer). Despite being highly reliable, since 
respondents cannot affect the magnitude of WTP value, it offers limited information 
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due to the fact that respondents are just asked to accept or reject a given value 
(Watson and Ryan, 2007). 
 
As mentioned in the previous section, demographic and socioeconomic 
characteristics and healthcare services satisfaction determinants seem to have an 
impact on WTP per QALY. More specifically, age (Lim et al., 2017; Sund and 
Svensson, 2017; Alayli-Goebbels et al., 2014; Martín-Fernández et al., 2014; 
Bobinac et al., 2010; Shiroiwa et al., 2010; Gyrd-Hansen, 2003), gender (Nimdet 
and Ngorsuraches, 2015; Alayli-Goebbels et al., 2014; Martín-Fernández et al., 
2014), educational level (Lim et al., 2017; Mavrodi et al., 2017; Sund and Svensson, 
2017; Alayli-Goebbels et al., 2014; Martín-Fernández et al., 2014; Shiroiwa et al., 
2013; Bobinac et al., 2010; Shiroiwa et al., 2010), marital status (Lim et al., 2017; 
Zhao et al., 2011), professional status (Sund and Svensson, 2017; Gao et al., 2015; 
Zhao et al., 2011; Shiroiwa et al., 2010; King et al., 2005), household size (Licke, 
Hens and Beutels, 2017; Martín-Fernández et al., 2014; Bobinac et al., 2010), 
household income (Lim et al., 2017; Mavrodi et al., 2017; Sund and Svensson, 
2017; Gao et al., 2015; Nimdet and Ngorsuraches, 2015; Alayli-Goebbels et al., 
2014; Martín-Fernández et al., 2014; Shiroiwa et al., 2013; Zhao et al., 2011; 
Bobinac et al., 2010; Shiroiwa et al., 2010; King et al., 2005; Gyrd-Hansen, 2003), 
health state (Shiroiwa et al., 2013; King et al., 2005), healthcare system satisfaction 
(Shiroiwa et al., 2010), access to healthcare services, quality of healthcare services 
and personnel (Gyrd-Hansen, 2016) have been found to affect WTP per QALY. 
Therefore, when designing a CV study such characteristics and determinants should 
be considered.  
 
Lastly, it is important to mention that when designing a CV study researchers should 
consider how to deal with those participants not willing to pay for the treatment, 
called protest responders. Protest responders refer to those participants that are 
unwilling to pay for the hypothetical treatment or report zero WTP value. This 
negative attitude could be because a) they cannot estimate their actual WTP value 
and thus, state zero WTP, b) do not want, indeed, to pay for the treatment, or c) 
believe that paying for the treatment is someone else’s responsibility (i.e. NHS’) 
(Fonta, Ichoku, Kabubo-Mariara, 2010; Dalmau-Matarrodona, 2001). Protest 
responders’ replies should be assessed thoroughly so as to identify the reasons 




3.1 Study Desing and Sample Population 
The research took place in January-February 2019. A representative, with regards to 
age, gender and region of residence, sample of the adult Greek population was 
randomly selected. Respondents’ recruitment was performed by the University 
Research Institute of the University of Macedonia, Thessaloniki Greece. 
Respondents completed the survey tool via telephone interviews through the 
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Computer-Assisted Telephone Interview (CATI) method, to ensure random sample 
selection.  
 
3.2 Research Tool 
A specially designed questionnaire constituted the research tool. The questionnaire 
consisted of four parts: i) assessment of respondents’ current health state; ii) WTP 
elicitation; iii) assessment of determinants; and iv) socioeconomic/demographic 
characteristics.  
 
For assessing respondents’ current health state the EuroQoL-5D-3L (EQ-5D-3L) 
tool was used. This tool is widely used in CV studies (Nimdet et al., 2015; Sund and 
Svensson, 2017). Respondents’ health state as reported using the EQ-5D-3L was 
translated into utility values based on the related reference values of Greek tariffs 
(Kontodimopoulos et al., 2008). Utility values range between 0 (death) and 1 
(perfect health) (Drummond et al., 2015). Few health states might be translated into 
negative utilities, indicating health states worse than death (Gray et al., 2012). In our 
study, deciding to assess participants’ current health state and conduct the survey via 
telephone interviews defined the choice of EQ-5D-3L over other relevant tools.  
 
To elicit WTP, respondents were provided with the following hypothetical scenario: 
“I would like you to imagine that there is a new treatment available in the market, 
which is not reimbursed by the NHS or any private insurance. For as long as you 
are administered this treatment, you are relieved from any health problem you are 
experiencing and you recover to perfect health, with no symptoms, no side effects 
and no risk associated with the treatment. This treatment is administered to you for 
as long as you are paying for it from your net household income”. This scenario was 
followed by a filter question (Donaldson et al., 2011): “Would you be willing-to-pay 
for this treatment? Yes or No?”. This filter question allowed us to clearly identify 
protest responders and assess their characteristics separately. Respondents replying 
positively to the filter question were then asked to elicit their maximum WTP value 
through the iterative bidding technique. The study focused on individual perspective, 
since participants were asked to consider a treatment that would improve their own 
health. Our choice of the iterative bidding technique, as an elicitation method, was 
guided primarily by the survey method (telephone interviews), which prohibited the 
use of methods requiring visual aids like the payment card, and the fact that no 
similar treatment is available in the market, meaning that no reference values exist, 
prohibiting the use of the dichotomous choice elicitation method.  
 
For the iterative bidding technique the lower bid was €1 and the maximum bid 
€8,192. Starting from the lower (maximum) bid, after participants’ positive 
(negative) response, the payment was doubled (halved) until they were unwilling 
(willing) to pay the specified amount (Mavrodi et al., 2017; Gao et al., 2015; 
Martín-Fernández et al., 2014; Zhao et al., 2011; King et al., 2005). Following a 
previously used rule (King et al., 2005; Gao et al., 2015), the maximum bid was set 
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at 10 times the monthly net national disposable income (€13,991), without tough 
exceeding it (Hellenic Statistical Authority …, 2019). 
 
In the third part of the questionnaire respondents’ overall satisfaction from 
healthcare services provision was examined through a 0-10 satisfaction scale (0 
referring to extremely dissatisfied and 10 to extremely satisfied) (Shiroiwa et al., 
2010). Access to healthcare services, quality of healthcare services and personnel 
were assessed through three pre-defined statements (Gyrd-Hansen, 2016) for which 
respondents were asked to state the extent to which they agree with each statement 
(to a great/moderate/little extent/not at all). It is important to note that quality of 
healthcare personnel was measured indirectly by assessing doctors’ respectfulness. 
Evaluating doctors’ medical knowledge and expertise is difficult and subjective. 
Therefore, we decided to focus on an indirect quality measurement, which would be 
easier for participants to assess. 
 
Lastly, respondents had to provide information regarding their age, gender, 
educational level, professional status, marital status, household size, number of 
household members that hold either a part- or full-time job and net monthly 
disposable household income.  
 
3.3 Data Analysis 
Elicitation of the WTP per QALY value was based on participants expressing a 
utility value less than 1. Perfect health participants (utility=1) were excluded from 
the analyses to avoid zero QALY gains and division by a zero denominator 
(Mavrodi et al., 2017; Gao et al., 2015; Byrne, O’Malley and Suarez, 2005). 
Moreover, protest responders -participants stating ‘no’ in the filter question- were, 
also, excluded from the WTP per QALY estimation. Using the EQ-5D-3L Greek 
tariffs, a utility value for each participant was computed. WTP per QALY was 
estimated as the ratio of the annual stated WTP over utility improvement from 
individual’s current health to perfect health (Mavrodi et al., 2017; Gao et al., 2015; 
Martín-Fernández et al., 2014; Zhao et al., 2011; Nimdet and Ngorsuraches 2015). It 
is important to note that discount rate and life expectancy were not considered, since 
in our analysis we captured payment for only one year.  
 
Descriptive statistics are provided for the WTP per QALY estimate and, also, for 
those participants willing to pay and for protest responders. 
Socioeconomic/demographic characteristics and satisfaction determinants 
differences between participants willing to pay and protest responders were assessed 




4.1 Preliminary WTP per QALY Estimation 
A representative, with regards to age, gender and region of residence, sample of 
1,342 subjects participated in the survey. 410 participants (30.6%) were excluded 
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from WTP per QALY estimations since they were in a state of perfect health 
(utility=1). Out of the remaining subjects, 528 (39.3%) were willing to pay for the 
hypothetical treatment, whereas 395 (29.4%) were identified, via the filter question, 
as protest responders and 9 participants refused to answer the WTP valuation 
question. The mean and median WTP per QALY estimate were €26,280 (standard 
deviation was €83,547) and €2,793 (interquartile range was €14,427), respectively. 
The minimum WTP per QALY estimate was €17 and the maximum €646,737.  
 
4.2 Preliminary Analysis of Demographic and Socioeconomic Characteristics 
Demographic and socioeconomic characteristics of those willing to pay and protest 
responders are given in the following Table 1. The two participants groups differed 
significantly with respect to age (p=0.000), household size (p=0.018), number of 
household members having a part- or full-time job (p=0.000), education (p=0.000), 
marital status (p=0.000), household income (p=0.000) and utility (p=0.003).  
 
Table 1. Demographic and socioeconomic characteristics of study participants 
willing to pay for the hypothetical treatment (n=528) and of protest responders 
(n=395)  






Gender: woman [N (%)] 281 (53.2) 227 (57.5) 0.133a 
Age (years) [mean (SD)] 46.2 (16.6) 53.9 (17.7) 0.000b 
Household size [mean (SD)] 3.0 (1.3) 2.8 (1.3) 0.018b 
Number of household members holding a full-time 







Education [N (%)]    
No/Elementary  19 (3.6) 56 (14.2) 
0.000a 
High School 179 (33.9) 161 (40.8) 
Private College (IEK) 55 (10.4) 40 (10.1) 
Higher education (University)  274 (52.0) 138 (34.9) 
Professional status [N (%)]    
Employed for wages 175 (33.1) 109 (27.6) 
0.000a 
Freelancer  122 (23.1) 58 (14.7) 
Pensioner 106 (20.1) 125 (31.6) 
Student 40 (7.7) 19 (4.9) 
Unemployed  79 (15.0) 76 (19.2) 
Marital Status [N (%)]    
Unmarried 184 (35.1) 81 (20.8) 
0.000a 
Married 304 (57.8) 246 (63.0) 
Divorced 16 (3.0) 22 (5.7) 
Widowed  22 (4.1) 41 (10.5) 
Net monthly disposable household income [N (%)]    
Less than €500 59 (11.6) 62 (16.7) 
0.000a 
€500-€1000 160 (31.6) 169 (45.7) 
€1001-€1500 148 (29.1) 80 (21.6) 
€1501-€2000 75 (14.9) 41 (11.2) 
More than €2000 65 (12.9) 18 (4.8) 
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aChi-square test, a=0.05; bIndependent Samples Mann-Whitney U Test, a =0.05. Numbers do 
not round up due to missing values not presented here.  
Source: Authors’ calculations. 
 
4.3 Preliminary Analysis of Satisfaction Determinants 
 Preliminary results regarding the four satisfaction determinants under examination 
are presented in Table 2. Protest responders compared to participants willing to pay 
seemed to believe to a higher extent that public hospitals and health centres offer 
high quality services (p=0.000) and employ high quality personnel (p=0.005). 
Participants‘ responses with respect to equity in access did not differ significantly 
between the two participants groups. Similarly, overall satisfaction rate did not differ 
significantly between the two participants groups. However, both participants groups 
reported, in absolute numbers, a satisfaction score slightly below 5.  
 
Table 2. National healthcare services satisfaction rate and national healthcare 
services provision assessment for those willing to pay for the hypothetical treatment 
(n=528) and protest responders (n=395)   






National healthcare services overall satisfaction 
rate* [mean (SD)]  
4.4 (2.4) 4.6 (2.7) 0.270a 
Pre-defined statements assessing healthcare services provision: To what extent do you agree with 
the following statements …  
1. All Greek citizens have equal access** to public 
healthcare services [N (%)] 
   
Agree to a great extent 122 (23.3) 74 (19.3) 
0.094b 
Agree to a moderate extent 192 (36.7) 140 (36.5) 
Agree to a little extent 91 (17.4) 57 (14.9) 
Not agree at all 118 (22.6) 112 (29.3) 
2. Public hospitals and health centres offer 
healthcare services of high quality [N (%)] 
   
Agree to a great extent 40 (7.7) 58 (15.0) 
0.000b 
Agree to a moderate extent 220 (42.3) 167 (43.1) 
Agree to a little extent 131 (25.1) 63 (16.0) 
Not agree at all 130 (24.9) 100 (25.9) 
3. Doctors in public hospitals and health centres are 
respectful [N (%)] 
   
Agree to a great extent 165 (31.5) 144 (37.0) 
0.005b 
Agree to a moderate extent 232 (44.2) 186 (47.9) 
Agree to a little extent 67 (12.8) 32 (8.3) 
Not agree at all 61 (11.6) 26 (6.8) 
aIndependent Samples Mann-Whitney U Test, a=0.05; bChi-square test, a=0.05. 
*Satisfaction rate is measured on a 0-10 scale, where 0 is extremely dissatisfied and 10 
extremely satisfied; **By the term “access”, it is meant the distance from the closest 
specialised doctor and/or the distance from the closest tertiary hospital and/or the waiting 
time from appointment setting till visiting a hospital doctor or a sickness fund doctor. 
Source: Authors’ calculations. 
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To the best of our knowledge, this is the first Greek study to elicit a monetary value 
to a health improvement employing a representative sample of the general Greek 
population, and assess differences between individuals willing to pay, for such an 
improvement, and protest responders.  
 
Preliminary findings revealed that the general Greek population is willing to pay 
€26,280 for an additional QALY. The above WTP per QALY estimate falls within 
the WHO’s criterion currently used in Greek healthcare economic evaluations –one 
to three times the country’s GDP per capita, the Greek GDP per capita for 2018 was 
€15,446 (IMF, 2019). Therefore, the WHO threshold used in Greek economic 
evaluations is by no means unreasonable or inappropriate.  
 
The estimated WTP per QALY value differed from that found in the literature. 
Studies with individual perspective and focus on the general population like ours, 
reported either higher (Bobinac et al., 2012; Zhao et al., 2011; Bobinac et al., 2010; 
Gyrd-Hansen, 2003) or lower (Shiroiwa et al., 2013; Gyrd-Hansen and Kjaer, 2012; 
Pinto-Prades, Loomes and Brey, 2009) estimates (in 2019 Euros).  
 
These dissimilarities could be explained considering the different 
demographic/socioeconomic characteristics of the samples (Bobinac et al., 2010; 
Pinto-Prades, Loomes and Brey, 2009) and the different elicitation techniques 
(Shiroiwa et al., 2013; Bobinac et al., 2012; Gyrd-Hansen and Kjaer, 2012; Bobinac 
et al., 2010; Pinto-Prades, Loomes and Brey, 2009; Gyrd-Hansen, 2003). Moreover, 
studies adopting the same elicitation technique as our study but with samples from 
patient-specific populations showed lower WTP per QALY estimates (Mavrodi et 
al., 2017; Gao et al., 2015; Martín-Fernández et al., 2014; King et al., 2005).   
 
Analysis of participants’ demographic/socioeconomic characteristics revealed that 
protest bidders are, on average, older, have to financially support families with less 
working members, have lower educational level, have more pensioners and 
unemployed and more married and widowed among their rankings compared to 
those willing to pay and are less affluent. Hence, protest responders in our study 
might be unwilling to pay for the treatment due to lower life expectancy and the 
tendency observed among elder individuals to accept more easily deteriorating 
health (Gyrd-Hansen, 2003). Another explanation could be their inability to afford 
such a treatment because of increased household financial needs and/or limited 
household budget.  
 
Considering the satisfaction determinants, our analysis showed that, on average, 
both participants groups are slightly dissatisfied (satisfaction score below 5) 
regarding the Greek NHS services. During the past decade Greece is undergoing a 
severe debt crisis that has indisputably affected the Greek NHS. The latter has to 
finance an increased demand for public services through a rather shrunk budget. 
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Understaffing, fewer resources, deterioration of access to and provision of healthcare 
services are only few of the problems the Greek NHS faces, affecting undoubtedly 
the quality of healthcare provision (Simou and Koutsogeorgou, 2014) and thus, 
individuals satisfaction. Assessment of NHS services provision through the three 
pre-defined statements revealed that differences do exist between the two 
participants groups with regards to their view towards access and quality of 
healthcare services and quality of healthcare personnel. However, further analysis is 




The present study constitutes a first attempt to elicit a WTP value for an additional 
QALY considering the general Greek population. Our preliminary findings suggest 
that the WHO’s criterion currently used in Greek economic evaluations is 
appropriate. However, further research and sub-group analysis is essential in order to 
confirm and validate this outcome. Moreover, individuals that are willing to pay for 
the hypothetical treatment bare different demographic and socioeconomics 
characteristics and their behaviour is affected by different determinants compared to 
those not willing to pay (protest responders). One could argue that the above results 
could be significant for the Greek healthcare policy-makers, since they might 
facilitate resources allocation and identification of groups of citizens that might be 
willing to pay out-of-pocket for such a treatment. 
 
It is important to note that the present study is subject to one major limitation: 
satisfaction determinants are assessed through pre-defined statements. Despite the 
fact that these statements derived from the literature, they might not cover all 
parameters that might affect an individual’s satisfaction regarding healthcare 
services provision.     
 
Lastly, since this is a preliminary study, our aim is to further investigate through 
regression analysis the effect of demographic/socioeconomic characteristics and 
satisfaction determinants on the magnitude of the WTP per QALY estimate 
(multiple linear regression) and individual’s tendency to pay or not for the 
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